Puma Biotechnology, Inc. SEC filings PBYI
Puma Biotechnology, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Oct 25, 2012. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Aug 27, 2024 | — |
| 424B3 | Prospectus | Aug 2, 2022 | — |
| S-3 | Shelf registration | Jul 25, 2022 | — |
| 424B5 | Prospectus supplement | Nov 4, 2021 | — |
| S-8 | Employee stock plan registration | Sep 16, 2021 | — |
| S-3 | Shelf registration | Jul 2, 2021 | — |
| S-8 | Employee stock plan registration | Feb 28, 2020 | — |
| S-8 | Employee stock plan registration | Jul 19, 2017 | — |
| S-8 | Employee stock plan registration | May 31, 2017 | — |
| 424B5 | Prospectus supplement | Oct 21, 2016 | — |
| FWP | Free writing prospectus | Oct 20, 2016 | — |
| 424B5 | Prospectus supplement | Oct 18, 2016 | — |
| S-8 | Employee stock plan registration | Jun 19, 2015 | — |
| 424B2 | Prospectus | Jan 22, 2015 | — |
| 424B5 | Prospectus supplement | Jan 20, 2015 | — |
| S-3ASR | Automatic shelf registration | Jan 20, 2015 | — |
| S-8 | Employee stock plan registration | Jun 24, 2014 | — |
| 424B1 | Filing | Feb 11, 2014 | — |
| S-3MEF | Filing | Feb 10, 2014 | — |
| S-3/A | Filing | Feb 10, 2014 | — |
| S-3 | Shelf registration | Jan 29, 2014 | — |
| 424B3 | Prospectus | Apr 12, 2013 | — |
| POS AM | Filing | Apr 4, 2013 | — |
| 424B3 | Prospectus | Feb 21, 2013 | — |
| 424B3 | Prospectus | Nov 14, 2012 | — |
Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PBYI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Los Angeles, CA
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1401667
- Former names
- INNOVATIVE ACQUISITIONS CORP (until Oct 4, 2011)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.